Abstract
A group of sera from hospital patients and normal subjects has been tested for the presence of antinuclear antibodies, and the amount of labile inhibitor to desoxyribonuclease 1 present in each of the sera estimated. It has been found that the presence of antinuclear antibodies is associated with a high level of inhibitor to a statistically significant degree.
It has also been found that this inhibitor is formed during the clotting of whole blood and that it is derived from platelets. A possible relationship between the inhibitor, its formation during the clotting of blood, and the characteristic presence of antinuclear antibodies in systemic lupus erythematosus is discussed.
Full text
PDF![447](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aee/1578906/65f538875d3b/clinexpimmunol00348-0070.png)
![448](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aee/1578906/fb3bb0f9b617/clinexpimmunol00348-0071.png)
![449](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aee/1578906/e06ab7fad7eb/clinexpimmunol00348-0072.png)
![450](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aee/1578906/02975f27a3be/clinexpimmunol00348-0073.png)
![451](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aee/1578906/551ba444b7b3/clinexpimmunol00348-0074.png)
![452](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aee/1578906/546d0e058f1c/clinexpimmunol00348-0075.png)
![453](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aee/1578906/bc4581f68dcc/clinexpimmunol00348-0076.png)
![454](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aee/1578906/a72d8b31a6da/clinexpimmunol00348-0077.png)
![455](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aee/1578906/27942b9d5293/clinexpimmunol00348-0078.png)
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- FEINSTEIN R. N., GREEN F. O. An activator of deoxyribonuclease in rat plasma. Arch Biochem Biophys. 1956 Feb;60(2):502–504. doi: 10.1016/0003-9861(56)90458-1. [DOI] [PubMed] [Google Scholar]
- FEINSTEI R. N. Activation of the neutral deoxyribonuclease. J Biol Chem. 1960 Mar;235:733–737. [PubMed] [Google Scholar]
- GUPTA S., HERRIOTT R. M. Nucleases and their inhibitors in the cellular components of human blood. Arch Biochem Biophys. 1963 Apr;101:88–95. doi: 10.1016/0003-9861(63)90538-1. [DOI] [PubMed] [Google Scholar]
- HENSTELL H. H., FREEDMAN R. I. The viscosimetric determination of desoxyribonuclease inhibition. Cancer Res. 1952 May;12(5):341–345. [PubMed] [Google Scholar]
- HUMPHREY J. H., JAQUES R. The release of histamine and 5-hydroxytryptamine (serotonin) from platelets by antigen-antibody reactions (in vitro). J Physiol. 1955 Apr 28;128(1):9–27. doi: 10.1113/jphysiol.1955.sp005289. [DOI] [PMC free article] [PubMed] [Google Scholar]
- JOHNSON A. J., GOGER P. R., TILLETT W. S. The intravenous injection of bovine crystalline pancreatic desoxyribonuclease into patients. J Clin Invest. 1954 Dec;33(12):1670–1686. doi: 10.1172/JCI103048. [DOI] [PMC free article] [PubMed] [Google Scholar]
- KURNICK N. B., SCHWARTZ L. I., PARISER S., LEE S. L. A specific inhibitor for human desoxyribonuclease and an inhibitor of the lupus erythematosus cell phenomenon from leucocytes. J Clin Invest. 1953 Mar;32(3):193–201. doi: 10.1172/JCI102727. [DOI] [PMC free article] [PubMed] [Google Scholar]